Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The pathologist in litigation: a scientist's perspective

J W Newberne1

  • 1Marion Merrell Dow Inc., Cincinnati, Ohio 45215.

Toxicologic Pathology
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polybenzarsol; a new amebicide.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor.

Toxicologic pathology·1990
Same author

A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats.

Toxicologic pathology·1987
Same author

Preclinical safety studies with terfenadine.

Arzneimittel-Forschung·1982
Same author

An aid to clinical diagnosis of tongue worms (Linguatula serrata) in dogs.

Laboratory animal science·1981
Same author

Lack of carcinogenicity of oxprenolol, a beta-adrenergic blocking agent.

Toxicology and applied pharmacology·1977
Same journal

Comparison of Standard Clinical Pathology Parameter Values in Fasted and Fed Rats and Non-human Primates.

Toxicologic pathology·2026
Same journal

Time-Dependent Autolysis in Ex Vivo-Maintained Rat Tissue in Saline: A Descriptive Study and Practical Guidance for Histopathologic Assessment.

Toxicologic pathology·2026
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
See all related articles

The increasing number of lawsuits means pathologists will likely face litigation, particularly concerning toxic tort and product liability cases. Understanding these legal risks is crucial for medical professionals.

Area of Science:

  • Forensic Pathology
  • Legal Medicine

Background:

  • Societal litigiousness is rising, evidenced by extensive advertising from personal injury lawyers.
  • Pathologists are increasingly involved in legal proceedings, particularly in toxic tort cases.

Purpose of the Study:

  • To inform pathologists about the growing likelihood of involvement in litigation.
  • To highlight the specific area of product (toxic tort) liability as a common source of legal challenges.

Main Methods:

  • Analysis of societal trends in litigation.
  • Review of legal advertising and professional directories.

Main Results:

  • Personal injury lawyers heavily advertise, indicating a high volume of litigation.
  • Pathologists can anticipate increased engagement in legal cases, especially product liability.

Related Experiment Videos

Conclusions:

  • Pathologists must be prepared for potential litigation throughout their careers.
  • Specialized knowledge in toxic tort and product liability is essential for forensic pathologists.